FMC Corp. stock holds after recent results and guidance
Published on 07/20/2026 at 15:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
FMC Corp. (US3024913036) stock is anchored by its latest reported quarter, with Q1 2026 revenue of $918 million, adjusted EPS of $0.18, and full-year 2026 adjusted EPS guidance of $3.26 to $3.70. The company also reported adjusted EBITDA of $166 million and adjusted EBITDA margin of 18.1% for the quarter, giving investors a clear read on profitability and execution.
Q1 2026 margin and earnings
Management said Q1 2026 revenue rose 3% year over year, while adjusted EBITDA increased to $166 million from $160 million a year earlier, a modest but visible improvement in operating earnings. Adjusted EPS of $0.18 compared with $0.69 in Q1 2025, showing that bottom-line recovery still lags the top-line trend.
The market backdrop matters because FMC shares have been moving against a tougher agricultural crop protection cycle, and the quarter showed how pricing, mix, and volume can offset one another. For investors, the spread between $918 million in revenue and $166 million in adjusted EBITDA is the key figure to watch because it shows how much operating income is left after costs.
Guidance at $3.26 to $3.70
FMC kept full-year 2026 adjusted EPS guidance at $3.26 to $3.70, which frames the next quarters as a test of whether the business can hold its first-quarter improvement. That range is the central comparison point for the stock because it gives a concrete earnings corridor for the rest of fiscal 2026.
The company also guided to adjusted EBITDA of $800 million to $900 million for 2026, a broader operating target that places the Q1 result inside a full-year plan rather than as a stand-alone improvement. Revenue from continuing operations was $918 million in the quarter, so the implied challenge is to sustain that scale while preserving margin.
Revenue and cost mix
The 3% year-over-year revenue increase in Q1 2026 is the cleanest directional signal in the latest report, but the much larger gap between adjusted EPS and last year’s $0.69 shows how sensitive FMC remains to costs and mix. Adjusted EBITDA margin of 18.1% provides a better operating lens than earnings alone because it strips out some of the noise from below-the-line items.
That mix is important in crop chemicals, where volume, channel inventory, and product timing can change quarter to quarter. FMC’s reported numbers suggest the company is still working through that cycle, while the guidance range implies management expects a better full-year balance than the first quarter alone might suggest.
Seed treatment focus
A representative product line for FMC is its seed treatment and crop protection portfolio, which sits at the center of its agricultural seasonality. In Q1 2026, the company’s reported operating numbers matter more than product branding because investors are watching whether the portfolio can convert revenue into steadier earnings.
The stock closing level is omitted here because a dated quote was not available in the supplied search results, so the relevant market anchor in this article is the company’s own Q1 2026 and full-year 2026 figures. That keeps the focus on evidenced operating data rather than an unverified price snapshot.
Shares and valuation
FMC Corp. remains a reporting-driven stock, with Q1 2026 revenue of $918 million, adjusted EBITDA of $166 million, and full-year 2026 adjusted EPS guidance of $3.26 to $3.70 forming the clearest factual frame for the name. Those figures show a company that is stabilizing earnings power, but not yet back to the stronger earnings level implied by the prior-year quarter.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
